β-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells
暂无分享,去创建一个
[1] D. Grandy,et al. Opiate modulating properties of nociceptin/orphanin FQ☆ , 2000, Peptides.
[2] B. Hawes,et al. Nociceptin (ORL‐1) and μ‐Opioid Receptors Mediate Mitogen‐Activated Protein Kinase Activation in CHO Cells Through a Gi‐Coupled Signaling Pathway: Evidence for Distinct Mechanisms of Agonist‐Mediated Desensitization , 1998, Journal of neurochemistry.
[3] G. Henderson,et al. Antinociceptive and morphine modulatory actions of spinal orphanin FQ , 1998 .
[4] F. Monsma,et al. Interaction of [3H]orphanin FQ and 125I-Tyr14-orphanin FQ with the orphanin FQ receptor: kinetics and modulation by cations and guanine nucleotides. , 1997, Molecular pharmacology.
[5] Xiao-jun Xu,et al. Lack of cross-tolerance between the antinociceptive effect of intrathecal orphanin FQ and morphine in the rat , 1997, Neuroscience Letters.
[6] R. DesJarlais,et al. Determination of the Amino Acid Residue Involved in [3H]β-Funaltrexamine Covalent Binding in the Cloned Rat μ Opioid Receptor* , 1996, The Journal of Biological Chemistry.
[7] A. I. Brooks,et al. Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells. , 1994, The Journal of pharmacology and experimental therapeutics.